171 related articles for article (PubMed ID: 22099423)
1. Adiponectin and atherosclerosis risk factors in African hemodialysis patients: a population at low risk for atherosclerotic cardiovascular disease.
Amira OC; Naicker S; Manga P; Sliwa K; Mia A; Raal F; Crowther NJ; Immelman RA; Olorunju S
Hemodial Int; 2012 Jan; 16(1):59-68. PubMed ID: 22099423
[TBL] [Abstract][Full Text] [Related]
2. Plasma adiponectin levels for prediction of cardiovascular risk among hemodialysis patients.
El-Shafey EM; Shalan M
Ther Apher Dial; 2014 Apr; 18(2):185-92. PubMed ID: 24720410
[TBL] [Abstract][Full Text] [Related]
3. Adiponectin and cardiovascular outcomes among hemodialysis patients.
Abdallah E; Waked E; Nabil M; El-Bendary O
Kidney Blood Press Res; 2012; 35(4):247-53. PubMed ID: 22286012
[TBL] [Abstract][Full Text] [Related]
4. Association between plasma adiponectin concentration and visceral fat accumulation in hemodialysis patients.
Odamaki M; Furuya R; Kinumura Y; Ikegaya N; Kumagai H
Nephron Clin Pract; 2006; 102(1):c8-13. PubMed ID: 16166803
[TBL] [Abstract][Full Text] [Related]
5. Adiponectin levels and arteriosclerotic risk factors in pediatric renal transplant recipients.
Bakkaloglu SA; Soylemezoglu O; Buyan N; Oktar SO; Funahashi T; Pasaoglu H; Elhan AH; Peru H; Hasanoglu E
Pediatr Transplant; 2006 Mar; 10(2):187-92. PubMed ID: 16573605
[TBL] [Abstract][Full Text] [Related]
6. Plasma adiponectin levels in chronic kidney disease patients: relation with molecular inflammatory profile and metabolic status.
Norata GD; Baragetti I; Raselli S; Stucchi A; Garlaschelli K; Vettoretti S; Piloni G; Buccianti G; Catapano AL
Nutr Metab Cardiovasc Dis; 2010 Jan; 20(1):56-63. PubMed ID: 19359150
[TBL] [Abstract][Full Text] [Related]
7. Atherosclerosis is associated with plasminogen activator inhibitor type-1 in chronic haemodialysis patients.
Peng Y; Liu H; Liu F; Ouyang L; Cheng M; Gao L; Pan F; Liu Y; Chen X; Li J
Nephrology (Carlton); 2008 Oct; 13(7):579-86. PubMed ID: 19161364
[TBL] [Abstract][Full Text] [Related]
8. [Analysis of metabolic syndrome and pulse wave velocity in hemodialysis patients: diagnosis of obesity by bioelectrical impedance analysis and a novel risk factor for atherosclerosis].
Sasaki N; Takeda S; Saito T; Ando Y; Kusano E
Nihon Jinzo Gakkai Shi; 2009; 51(4):476-83. PubMed ID: 19601557
[TBL] [Abstract][Full Text] [Related]
9. Plasma myeloperoxidase, NT-proBNP, and troponin-I in patients on CAPD compared with those on regular hemodialysis.
Al-Hweish A; Sultan SS; Mogazi K; Elsammak MY
Hemodial Int; 2010 Jul; 14(3):308-15. PubMed ID: 20597992
[TBL] [Abstract][Full Text] [Related]
10. Relationship of high-molecular-weight adiponectin levels to visceral fat accumulation in hemodialysis patients.
Tamei N; Ogawa T; Ishida H; Ando Y; Nitta K
Intern Med; 2010; 49(4):299-305. PubMed ID: 20154435
[TBL] [Abstract][Full Text] [Related]
11. Body fat percentage as a risk factor for atherosclerosis but not for inflammation for hemodialysis patients: differences between genders.
Sezer S; Karakan S; Saşak G; Tutal E; Ozdemir Acar FN
J Ren Nutr; 2012 Sep; 22(5):490-8. PubMed ID: 22153383
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular risk factors in hemodialysis and peritoneal dialysis patients.
Helal I; Smaoui W; Hamida FB; Ouniss M; Aderrahim E; Hedri H; Elyounsi F; Maiz HB; Abdallah TB; Kheder A
Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):59-62. PubMed ID: 20061694
[TBL] [Abstract][Full Text] [Related]
13. Association between hypoadiponectinemia and cardiovascular risk factors in nonobese healthy adults.
Im JA; Kim SH; Lee JW; Shim JY; Lee HR; Lee DC
Metabolism; 2006 Nov; 55(11):1546-50. PubMed ID: 17046559
[TBL] [Abstract][Full Text] [Related]
14. Oxidative DNA damage correlates with carotid artery atherosclerosis in hemodialysis patients.
Ari E; Kaya Y; Demir H; Cebi A; Alp HH; Bakan E; Odabasi D; Keskin S
Hemodial Int; 2011 Oct; 15(4):453-9. PubMed ID: 22111813
[TBL] [Abstract][Full Text] [Related]
15. Cardiac troponin I and beta 2 microglobulin as risk factors for early-onset atherosclerosis in patients on haemodialysis.
Zumrutdal A; Sezer S; Demircan S; Seydaoglu G; Ozdemir FN; Haberal M
Nephrology (Carlton); 2005 Oct; 10(5):453-8. PubMed ID: 16221094
[TBL] [Abstract][Full Text] [Related]
16. Carotid atherosclerosis and endothelial cell adhesion molecules as predictors of long-term outcome in chronic hemodialysis patients.
Papagianni A; Dovas S; Bantis C; Belechri AM; Kalovoulos M; Dimitriadis C; Efstratiadis G; Alexopoulos E; Memmos D
Am J Nephrol; 2008; 28(2):265-74. PubMed ID: 17989499
[TBL] [Abstract][Full Text] [Related]
17. Is there any relationship between serum levels of interleukin-10 and atherosclerosis in hemodialysis patients?
Seyrek N; Karayaylali I; Balal M; Paydas S; Aikimbaev K; Cetiner S; Seydaoglu G
Scand J Urol Nephrol; 2005; 39(5):405-9. PubMed ID: 16257843
[TBL] [Abstract][Full Text] [Related]
18. Atherosclerosis and vascular calcification are independent predictors of left ventricular hypertrophy in chronic haemodialysis patients.
Yildiz A; Memisoglu E; Oflaz H; Yazici H; Pusuroglu H; Akkaya V; Erzengin F; Tepe S
Nephrol Dial Transplant; 2005 Apr; 20(4):760-7. PubMed ID: 15716296
[TBL] [Abstract][Full Text] [Related]
19. Association of high-molecular-weight to total adiponectin ratio with pulse wave velocity in hemodialysis patients.
Kato A; Odamaki M; Ishida J; Hishida A
Nephron Clin Pract; 2008; 109(1):c18-24. PubMed ID: 18493156
[TBL] [Abstract][Full Text] [Related]
20. Decreased high-density lipoprotein cholesterol is associated with inflammation and insulin resistance in non-diabetic haemodialysis patients.
Peng YS; Chiu YL; Chen HY; Yang JY; Lai CF; Hsu SP; Pai MF
Nephrology (Carlton); 2010 Oct; 15(7):692-9. PubMed ID: 21040164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
